Literature DB >> 16377717

Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates.

Ellie J C Goldstein1, Diane M Citron, C Vreni Merriam, Yumi A Warren, Kerin L Tyrrell, Helen T Fernandez.   

Abstract

Using the NCCLS agar dilution method, we studied the in vitro activity of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium species, including seven multiresistant strains, and found retapamulin to be the most active agent among those tested with MICs of < or = 1 microg/ml against all isolates.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16377717      PMCID： PMC1346797          DOI： 10.1128/AAC.50.1.379-381.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Epidemiology of acne.

Authors:  Brigitte Dreno; Florence Poli
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

2.  European surveillance study on the antibiotic susceptibility of Propionibacterium acnes.

Authors:  C Oprica; C E Nord
Journal:  Clin Microbiol Infect       Date:  2005-03       Impact factor: 8.067

Review 3.  Antibacterial therapy for acne: a guide to selection and use of systemic agents.

Authors:  Hiok-Hee Tan
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

4.  Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm.

Authors:  Cristina Oprica; Lennart Emtestam; Jan Lapins; Erik Borglund; Filippa Nyberg; Kajsa Stenlund; Lena Lundeberg; Eva Sillerström; Carl Erik Nord
Journal:  Anaerobe       Date:  2004-06       Impact factor: 3.331

5.  Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries.

Authors:  Cristina Oprica; Sonja Löfmark; Bodil Lund; Charlotta Edlund; Lennart Emtestam; Carl Erik Nord
Journal:  Anaerobe       Date:  2005-03-05       Impact factor: 3.331

6.  In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.

Authors:  Ellie J C Goldstein; Georg Conrads; Diane M Citron; C Vreni Merriam; Yumi Warren; Kerin Tyrrell
Journal:  Diagn Microbiol Infect Dis       Date:  2002-02       Impact factor: 2.803

Review 7.  Topical retinoid and antibiotic combination therapy for acne management.

Authors:  Jonathan S Weiss; Joel S Shavin
Journal:  J Drugs Dermatol       Date:  2004 Mar-Apr       Impact factor: 2.114

Review 8.  Antibiotic resistance in the topical treatment of acne vulgaris.

Authors:  James J Leyden
Journal:  Cutis       Date:  2004-06

Review 9.  Propionibacterium acnes resistance: a worldwide problem.

Authors:  E A Eady; M Gloor; J J Leyden
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

10.  Antibiotic-resistant acne: lessons from Europe.

Authors:  J I Ross; A M Snelling; E Carnegie; P Coates; W J Cunliffe; V Bettoli; G Tosti; A Katsambas; J I Galvan Peréz Del Pulgar; O Rollman; L Török; E A Eady; J H Cove
Journal:  Br J Dermatol       Date:  2003-03       Impact factor: 9.302
View more
  4 in total

Review 1.  Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.

Authors:  Lily P H Yang; Susan J Keam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity.

Authors:  Chen Davidovich; Anat Bashan; Tamar Auerbach-Nevo; Rachel D Yaggie; Richard R Gontarek; Ada Yonath
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-08       Impact factor: 11.205

3.  Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent.

Authors:  Maria M Traczewski; Steven D Brown
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

4.  Topical retapamulin in the management of infected traumatic skin lesions.

Authors:  Ribhi Shawar; Nicole Scangarella-Oman; Marybeth Dalessandro; John Breton; Monique Twynholm; Gang Li; Harmony Garges
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.